Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.13% | $5.88M | €338.67B | 38.66% | 76 Outperform | |
| AstraZeneca | 1.41% | $3.89M | £210.77B | 35.66% | 76 Outperform | |
| Novartis AG | 1.41% | $3.88M | CHF194.55B | 9.68% | 80 Outperform | |
| Roche Holding AG | 1.38% | $3.81M | CHF248.32B | 34.30% | 73 Outperform | |
| Royal Bank Of Canada | 1.28% | $3.54M | $207.93B | 17.80% | 75 Outperform | |
| Schneider Electric | 1.27% | $3.51M | €127.97B | -4.08% | 75 Outperform | |
| SAP SE | 1.26% | $3.49M | €239.84B | -7.29% | 66 Neutral | |
| HSBC Holdings | 1.20% | $3.30M | £179.93B | 43.68% | 79 Outperform | |
| ABB Ltd | 1.01% | $2.79M | kr1.18T | 12.97% | 78 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 0.97% | $2.68M | €303.03B | 8.93% | 78 Outperform |